Gadolinium chloride toxicity in the rat

Toxicologic Pathology

Volumn 25, Issue 3, 1997, Pages 245-255

  Spencer, Andrew J ^a   Wilson, Susan A ^a   Batchelor, John ^a   Reid, Alexandra ^a   Rees, Jeremy ^a,b   Harpur, Ernest ^a  

^a Alnwick Research Centre   (United Kingdom)

^b PHILIPS RESEARCH LABORATORIES   (Netherlands)

Author keywords

Coagulation; Kidney; Liver; Lung; Mineralization; Spleen; Stomach

Indexed keywords

GADOLINIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; LIVER NECROSIS; MALE; MINERALIZATION; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RAT; SPLEEN DISEASE; TOXICITY TESTING;

ANIMALIA;

EID: 0030986885     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339702500301     Document Type: Article

References (26)

1. Aster RH (1966). Pooling of platelets in the spleen: Role in the pathogenesis of 'hypersplenic' thrombocytopenia. J. Clin. Invest. 45: 645-657.
2. Barker IK and Van Dreumel AA (1985). The alimentary system In: Pathology of Domestic Animals, Vol. 2, NVF Jubb, PC Kennedy, and N Palmer (eds). Academic Press, San Diego, p. 54-56.
3. 3 and Gd-DTPA and their influence on proton magnetic relaxation in rats tissues. Magn. Reson. Imag. 5: 221-231.
4. Bruce DW, Hietbrink BE, and DuBois KP (1963). The acute mammalian toxicity of rare earth nitrates and oxides. Toxicol. Appl. Pharmacol. 5: 750-759.
5. Caille JM, Lemanceau B, and Bonnemain B (1983). Gadolinium as a contrast agent for NMR. Am. J. Neuroradiol. 4: 1041-1042.
6. Cheville NF (1979). Uremic gastropathy in the dog. Vet. Pathol. 16: 292-309.
7. Davies DT (1992). Enzymology in preclinical safety evaluation. Toxicol. Pathol. 20: 501-505.
8. Dean PB, Niemi P, Kivisaari L, and Kormano M (1988). Comparative pharmacokinetics of gadolinium DTPA and gadolinium chloride. Invest. Radiol. 23(suppl. 1): 258-260.
9. Evans CH (1990). Biochemistry of the Lanthanides. Plenum Press, New York, pp. 339-417.
10. Gilka F, Corner AH, Sugden EA, and Friend DW (1978). Heterotropic calcification in swine. Vet. Pathol. 15: 213-222.
11. Gopinath G, Prentice DE, and Lewis DJ (1987). Atlas of Experimental Toxicological Pathology. MTP Press, Lancaster, United Kingdom, p. 123.
12. Graca JC, Davison FC, and Feavel JB (1964). Comparative toxicity of stable rare earth compounds III. Acute toxicity of intravenous injections of chloride and chelates in dogs. Arch. Environ. Health 8: 555-564.
13. Haley TJ, Raymond K, Komesu N, and Upham HC (1961). Toxicological and pharmacological effects of gadolinium and samarium chloride. Brit. J. Pharmacol. 17: 526-532.
14. Haley PJ, Miller DM, Wilson SA, Harling E, and Spencer A. (1996). Gadolinium chloride-induced site-specific mineralization of the stomach in rats. Fund. Appl. Tox. 30(1, Pt. 2): 298.
15. Hardonk MJ, Dijkhuis FWJ, Hulstaert CE, and Koudstaal J (1992). Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J. Leukoc. Biol. 52: 296-302.
16. Harpur ES, Worah D, Hals P-A, Holtz E, Furuhama K, and Nomura H (1993). Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Invest. Radiol. 28(suppl. 1): 28-43.
17. Husztik E, Lazar G, and Parducz A (1980). Electron microscopic study of Kupffer-cell phagocytosis blockage induced by gadolinium chloride. Br. J. Exp. Pathol. 61: 624-630.
18. Lambert CE, Barnum EC, and Shapiro R (1990). Acute toxicological evaluation of gadolinium oxide. J. Am. Coll. Toxicol. 12: 620.
19. Lazar G (1973). The reticuloendothelial-blocking effect of rare earth metals in rats. J. Reticuloendothel. Soc. 13: 231-237.
20. Magnusson G (1963). The behaviour of certain lanthanons in rats. Acta Pharmacol. Toxicol. 20(suppl. 2): 1-95.
21. Selye H and Berczi I (1970). The present status of calciphylaxis and calcergy. Clin. Orth. Rel. Res. 69: 28-53.
22. Selye H, Szabo S, Tuchweber B, and Lefebvre F (1972). Acute miliary necrosis resembling peliosis hepatis produced by the combination of glucocorticoid and gadolinium chloride. Proc. Soc. Exp. Biol. Med. 139: 887-889.
23. Snyder F, Cress EA, and Kyker GC (1959). Liver lipid response to intravenous rare earths in rats. J. Lipid Res. 1: 125-131.
24. Wasserman AJ, Monticello TM, Feldman RS, Gitlitz PH, and Durham SK (1996). Utilization of electron probe microanalysis in gadolinium-treated mice. Toxicol. Pathol. 24: 588-594.
25. Weinmann H-J, Brasch RC, Press W-R, and Wesbey GE (1984). Characteristics of gadolinium-DTPA complex: A potential NMR contrast agent. Am. J. Roent. 142: 619-624.
26. Weissenger J (1992). Clinical pathology testing in preclinical safety assessment: regulatory concerns. Toxicol. Pathol. 20: 509-514.